Compare PBH & RHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PBH | RHI |
|---|---|---|
| Founded | 1996 | 1948 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.3B |
| IPO Year | 2005 | N/A |
| Metric | PBH | RHI |
|---|---|---|
| Price | $59.46 | $27.07 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 5 | 7 |
| Target Price | ★ $86.40 | $40.00 |
| AVG Volume (30 Days) | 454.8K | ★ 2.8M |
| Earning Date | 11-06-2025 | 10-22-2025 |
| Dividend Yield | N/A | ★ 8.73% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.04 | 1.54 |
| Revenue | $1,110,479,000.00 | ★ $5,458,499,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.69 | $0.90 |
| P/E Ratio | ★ $14.73 | $17.55 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $57.25 | $25.22 |
| 52 Week High | $90.04 | $78.41 |
| Indicator | PBH | RHI |
|---|---|---|
| Relative Strength Index (RSI) | 46.70 | 44.27 |
| Support Level | $57.25 | $26.77 |
| Resistance Level | $60.35 | $27.85 |
| Average True Range (ATR) | 1.53 | 1.06 |
| MACD | 0.11 | 0.35 |
| Stochastic Oscillator | 53.58 | 61.42 |
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry. The firm generates annual revenue of around $7 billion.